These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1490576)

  • 21. [Desferal treatment of hemosiderosis in hemoglobinopathies (based on records from Kuveit)].
    Khutsishvili GE
    Ter Arkh; 1971 Oct; 43(10):98-101. PubMed ID: 4258785
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of a case of idiopathic pulmonary hemosiderosis treated with an iron chelating agent (desferoxamine B, "Desferal")].
    Poggio GL; Lucioni F
    Minerva Med; 1967 Sep; 58(70):2985-93. PubMed ID: 6054090
    [No Abstract]   [Full Text] [Related]  

  • 23. [Desferal in the treatment of hemochromatosis].
    Pokora J; Matuszewski M; Sliwińska J
    Pol Tyg Lek; 1965 Aug; 20(32):1205-6. PubMed ID: 5845702
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemosiderosis and idiopathic hemochromatosis].
    Nowotny P
    Z Gesamte Inn Med; 1967 Dec; 22(24):799-806. PubMed ID: 5585476
    [No Abstract]   [Full Text] [Related]  

  • 25. [A NEW TEST ("DESFERAL TEST") FOR THE DEMONSTRATION OF PATHOLOGICAL IRON DEPOSITS IN THE ORGANISM].
    UNSELD DW
    Med Welt; 1964 Mar; 11():569-71. PubMed ID: 14188957
    [No Abstract]   [Full Text] [Related]  

  • 26. [Favorable effect of desferal on the clinical course of hemochromatosis].
    Miolin A; Radojicić B
    Vojnosanit Pregl; 1968 Mar; 25(3):144-5. PubMed ID: 5658834
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of hypersiderosis with Desferal].
    Anatkov A; Gekova K
    Vutr Boles; 1972; 11(6):56-9. PubMed ID: 4680042
    [No Abstract]   [Full Text] [Related]  

  • 28. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship.
    Silliman CC; Peterson VM; Mellman DL; Dixon DJ; Hambidge KM; Lane PA
    J Lab Clin Med; 1993 Jul; 122(1):48-54. PubMed ID: 8320490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial.
    Vichinsky E; Pakbaz Z; Onyekwere O; Porter J; Swerdlow P; Coates T; Lane P; Files B; Mueller BU; Coïc L; Forni GL; Fischer R; Marks P; Rofail D; Abetz L; Baladi JF
    Acta Haematol; 2008; 119(3):133-41. PubMed ID: 18408362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biologically active hydroxamic acids--iron complexons].
    Kol'tsova GN; Mel'nikovskaia NN; Likhodzievskiĭ KG; Rozenberg GIa
    Gematol Transfuziol; 1984 Sep; 29(9):56-9. PubMed ID: 6394425
    [No Abstract]   [Full Text] [Related]  

  • 31. [Isoferritin profile of serum ferritin in patient's with secondary hemosiderosis treated with desferrioxamine].
    Mariańska B; Eber M; Oberling F
    Acta Haematol Pol; 1982; 13(3-4):65-72. PubMed ID: 7184299
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnosis and therapy of iron overload with desferrioxamine].
    Andres J; Stobbe H
    Z Gesamte Inn Med; 1984 Apr; 39(8):167-9. PubMed ID: 6730593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current treatment of Cooley's anemia. Intravenous chelation therapy.
    Cohen AR; Martin M; Schwartz E
    Ann N Y Acad Sci; 1990; 612():286-92. PubMed ID: 2291556
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis of iron storage disease with desferrioxamine (Desferal test).
    Wöhler F
    Acta Haematol; 1964 Dec; 32(6):321-37. PubMed ID: 5005470
    [No Abstract]   [Full Text] [Related]  

  • 35. Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy.
    Breuer W; Ermers MJ; Pootrakul P; Abramov A; Hershko C; Cabantchik ZI
    Transfus Sci; 2000 Dec; 23(3):241-2. PubMed ID: 11099901
    [No Abstract]   [Full Text] [Related]  

  • 36. Transfusion hemosiderosis. Report of a case treated with desferrioxamine-B.
    Kaung DT
    J Iowa Med Soc; 1965 Jun; 55(6):312-6. PubMed ID: 5835475
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
    Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
    Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
    [No Abstract]   [Full Text] [Related]  

  • 38. [Erythroblastic aplasia in an adolescent].
    Fleury J; Soulier JP; de Menibus CH; Hazard E
    Nouv Rev Fr Hematol; 1970; 10(5):583-96. PubMed ID: 4250281
    [No Abstract]   [Full Text] [Related]  

  • 39. Deferoxamine for the treatment of hemosiderosis during CAPD.
    Gomez RA; Campbell F; Savory J; Chevalier RL
    Int J Pediatr Nephrol; 1987; 8(1):21-4. PubMed ID: 3583552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfusional hemosiderosis and combined chelation therapy in sickle thalassemia.
    Tsironi M; Polonifi K; Deftereos S; Farmakis D; Andriopoulos P; Moyssakis I; Aessopos A
    Eur J Haematol; 2005 Oct; 75(4):355-8. PubMed ID: 16146544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.